Influence of calcium channel blocker treatment on the mechanical properties of diabetic rat myocardium

Acta Diabetologica

Volumn 33, Issue 1, 1996, Pages 7-14

  Brown, R A ^a   Lee, M M ^a   Sundareson, A M ^a   Woodbury, D J ^a   Savage, A O ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Force of contraction; Myocardium; Nifedipine; Papillary muscle; Streptozotocin induced diabetes mellitus; Verapamil

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; NIFEDIPINE; PHOSPHOLIPID; STREPTOZOCIN; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMEGALY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; ELECTROSTIMULATION; HEART FUNCTION; HEART MUSCLE; HEART PAPILLARY MUSCLE; HEART SIZE; HEPATOMEGALY; HYPERGLYCEMIA; HYPERLIPIDEMIA; INOTROPISM; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER SIZE; MALE; MUSCLE TONE; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; RAT; WEIGHT GAIN;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CALCIUM CHANNEL BLOCKERS; DIABETES MELLITUS, EXPERIMENTAL; HEART; LACTATES; LIVER; MALE; MYOCARDIAL CONTRACTION; NIFEDIPINE; ORGAN SIZE; PAPILLARY MUSCLES; PHOSPHOLIPIDS; RATS; RATS, WISTAR; REFERENCE VALUES; VERAPAMIL;

EID: 0029866341     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00571933     Document Type: Article

References (40)

1. Fein FS. Diabetic cardiomyopathy. Diabetes Care 13:1169-1179, 1990
2. Fein FS, Kornstein LB, Strobeck JE, Capasso JM, Sonnenblick EH, Altered myocardial mechanics in diabetic rats. Circ Res 47:922-933, 1980
3. 2+ binding by and composition of the cardiac sarcolemmal membrane in chronic diabetes. Proc Natl Acad Sci USA 80 5412-5416, 1983
4. Ganguly PK, Pierce GN, Dhalla KS, Dhalla NS, Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol 244:E528-E535, 1983
5. 4. Am J Physiol 244:H592-H598, 1983
6. 2+ transport in streptozotocin-induced diabetic cardiomyopathy in rats Am J Physiol 253:E202-207, 1987
7. Dhalla NS, Pierce GN, Innes IR, Beamish RE, Pathogenesis of cardiac dysfunction in diabetes mellitus. Can J Cardiol 1:263-284, 1985
8. 3H]PN 200-110 binding to cardiac muscle membrane in streptozotocin-induced diabetic rats. Diabetes 39:1064-1069, 1990
9. Kashiwagi A, Nishio Y, Ogawa T, Tanaka S, Kodama M, Asahina T, Ikebuchi M, Shigeta Y, Increases in voltage-sensitive calcium channels of cardiac and skeletal muscle in streptozotocin-induced diabetic rats. In: Nagano M, Mochizuki S, Dhalla NS (eds) Cardiovascular disease in diabetes. Kluwer, Boston, 1992
10. Fein FS, Strobeck JE, Malhotra A, Scheuer J, Sonnenblick EH, Reversibility of diabetic cardiomyopathy with insulin in rats. Circ Res 49:1251-1261, 1981
11. Afzal N, Ganguly PK, Dhalla KS, Pierce GN, Singal PK, Dhalla NS, Beneficial effects of verapamil in diabetic cardiomyopathy. Diabetes 37:936-942, 1988
12. Kappelle AC, Braveboar B, Traber J, Erkelens DW, Gispen WH, The calcium antagonist nimedipine counteracts the onset of an experimental neuropathy in streptozotocin-induced diabetic rats. Neurosci Res Commun 10:95-104, 1992
13. Nayler WG, Slade AM, The cardioprotective effects of verapamil. Clin Exp Pharmacol Physiol (Suppl) 6:75-87, 1982
14. Douglas RR, John RC, Barry TM, Kenneth MK, Martin BL, Robert OB, Lewis CL, Stephen EE, Verapamil therapy, a new approach to pharmacological treatment of hypertrophic cardiomyopathy: effects of long-term administration. Am J Cardiol 48: 545-553, 1981
15. Chatterjee K, Raff G, Anderson D, William W, Parmley W, Hypertrophic-cardiomyopathy-therapy with slow channel inhibiting agents. Prog Cardiovasc Dis 25:193-209, 1982
16. Brown RA, Robinson E, Dunbar JC, Inotropic effects of ethanol on the isolated papillary muscle of the diabetic rat. Alcohol 10:231-235, 1993
17. Brown RA, Bhasin P, Savage A, Dunbar JC, Chronic verapamil treatment attenuates the negative inotropic effects of ethanol in diabetic rat myocardium. Can J Physiol Pharmacol 72:1013-1018, 1994
18. Bligh EG, Dyer WJ, A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917, 1959
19. Chen PS Jr, Toribara TY, Warner H, Microdetermination of phosphorus. Anal Chem 28:1156-1158, 1956
20. Ames BN, Dubin DT, The role of polyamines in the neutralization of bacteriophage deoxyribonucleic acid J Biol Chem 235:769-775, 1960
21. ++ channel density in rat tissue J Pharmacol Exp Ther 263:540-545, 1992
22. Martinez JL, Penna M, Influences of changes in calcium concentration and verapamil on the cardiac depressant effect of ethanol in cat papillary muscle. Gen Pharmacol 23:1051-1056, 1992
23. 2+- and spe cies-dependent systolic and diastolic contractile properties of intact muscle. J Gen Physiol 88:589-613, 1986
24. Koch-Weser J, Blinks JR, The influence of the interval between beats on myocardial contractility Pharmacol Rev 15:601-652, 1963
25. Levy J, Reid I, Halstad L, Gavin JR III, Avoili LV, Abnormal cell calcium concentrations in cultured bone cells obtained from femurs of obese and non-insulin-dependent diabetic rats. Calcif Tissue Int 44:131-137, 1989
26. Pierce GN, Afzal N, Kroeger EA et al. Cataract formation is prevented by administration of verapamil to diabetic rats. Endocrinology 125:730-735, 1989
27. Chan KM, Junger KD, The effect of streptozotocin-induced diabetes on the plasma membrane calcium uptake activity of rat liver. Diabetes 33:1072-1077, 1984
28. 2+)-ATPase response to insulin in kidney basolateral membranes of non-insulin-dependent diabetic rats. Metabolism 39:25-33, 1990
29. Allo SN, Lincoln TM, Wilson GL, Green FJ, Watanabe AM, Schaffer SW, Non-insulin-dependent diabetes-induces defects in cardiac cellular calcium regulation. Am J Physiol 260:C1165-1171, 1991
30. 2+ channel. Cardiovasc Res 24:381-389, 1990
31. 3H]Nitrendipine receptors in skeletal muscle. Properties and preferential localization in transverse tubules. J Biol Chem 258:6086-6092, 1983
32. Hess P, Tsien RW, Mechanism of ion permeation through calcium channels. Nature 309:453-456, 1984
33. Draznin B, Sussman KE, Eckel RH, Kao M, Yost T, Sherman NA, Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia. J Clin Invest 28:1848-1852, 1988
34. Draznin B, Lewis D, Houlder N et al. Mechanism of insulin resistance induced by sustained levels of cytosolic free calcium in rat adipocytes. Endocrinology 125:2341-2349, 1989
35. Pershadsingh HA, Shade DL, Delfert DM, MacDonald JM, Chelation of intracellular calcium blocks insulin action in the adipocyte. Proc Natl Acad Sci USA 84:1025-1029, 1987
36. Heijnis JB, Mathy MJ, van Zwieten PA, Effect of nifedipine on global myocardial ischemic injury in hearts from diabetic and age-matched controls. J Cardiovasc Pharmacol 18:542-547, 1991
37. Fein FS, Cho S, Malhotra A, Aakella J, van Hoeven KH, Sonnenblick EH, Beneficial effects of diltiazem on the natural history of hypertensive diabetic cardiomyopathy in rats. J Am Coll Cardiol 18:1406-1417, 1991
38. Hattori Y, Azuma M, Kemmotsu O, Kanno M, Differential sensitivity of diabetic rat papillary muscles to negative inotropic effects of oxybarbituates versus thiobarbituates. Anesth Analg 74:97-104, 1992
39. Fein FS, Aronson RS, Nordin C, Miller-Green B, Sonnenblick EH, Altered myocardial response to ouabain in diabetic rats: mechanics and electrophysiology. J Mol Cell Cardiol 15:769-784, 1983
40. Sonnenblick EH, Mechanism of myocardial contraction: the myocardial cell structure function and modification by cardiotonic drugs. University of Pennsylvania Press, Philadelphia, pp 173-250, 1966